IL-15 can signal via IL-15Rα, JNK, and NF-κB To drive RANTES production by myeloid cells

Journal of Immunology

Volumn 188, Issue 9, 2012, Pages 4149-4157

  Chenoweth, Meghan J ^a   Firoz Mian, M ^a   Barra, Nicole G ^a   Alain, Tommy ^b   Sonenberg, Nahum ^b   Bramson, Jonathan ^a   Lichty, Brian D ^a   Richards, Carl D ^a   Ma, Averil ^c   Ashkar, Ali A ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR GAMMA; JANUS KINASE; RAG2 PROTEIN; RANTES; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL COUNT; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; LYMPHOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SPLEEN SIZE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BONE MARROW CELLS; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL5; DENDRITIC CELLS; DNA-BINDING PROTEINS; HUMANS; IMMUNOLOGIC MEMORY; INFECTION; INTERLEUKIN-15; INTERLEUKIN-15 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-2 RECEPTOR BETA SUBUNIT; KILLER CELLS, NATURAL; MACROPHAGES; MAP KINASE KINASE 4; MICE; MICE, KNOCKOUT; NEOPLASMS; NF-KAPPA B; NUCLEAR PROTEINS; ORGAN SPECIFICITY; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS;

EID: 84860316416     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101883     Document Type: Article

References (38)

1. Mortier, E., R. Advincula, L. Kim, S. Chmura, J. Barrera, B. Reizis, B. A. Malynn, and A. Ma. 2009. Macrophage- and dendritic-cell-derived interleukin-15 receptor alpha supports homeostasis of distinct CD8+ T cell subsets. Immunity 31: 811-822.
2. Stonier, S. W., and K. S. Schluns. 2010. Trans-presentation: a novel mechanism regulating IL-15 delivery and responses. Immunol. Lett. 127: 85-92.
3. Ma, L. J., L. F. Acero, T. Zal, and K. S. Schluns. 2009. Trans-presentation of IL-15 by intestinal epithelial cells drives development of CD8alphaalpha IELs. J. Immunol. 183: 1044-1054.
4. Huntington, N. D., N. Legrand, N. L. Alves, B. Jaron, K. Weijer, A. Plet, E. Corcuff, E. Mortier, Y. Jacques, H. Spits, and J. P. Di Santo. 2009. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J. Exp. Med. 206: 25-34.
5. Ohteki, T., K. Suzue, C. Maki, T. Ota, and S. Koyasu. 2001. Critical role of IL-15-IL-15R for antigen-presenting celzl functions in the innate immune response. Nat. Immunol. 2: 1138-1143. (Pubitemid 33130148)
6. Dubois, S. P., T. A. Waldmann, and J. R. Müller. 2005. Survival adjustment of mature dendritic cells by IL-15. Proc. Natl. Acad. Sci. USA 102: 8662-8667. (Pubitemid 40862792)
7. Pelletier, M., and D. Girard. 2006. Differential effects of IL-15 and IL-21 in myeloid (CD11b+) and lymphoid (CD11b-) bone marrow cells. J. Immunol. 177: 100-108. (Pubitemid 43939121)
8. Gil, M., S. J. Park, Y. S. Chung, and C. S. Park. 2010. Interleukin-15 enhances proliferation and chemokine secretion of human follicular dendritic cells. Immunology 130: 536-544.
9. Budagian, V., E. Bulanova, R. Paus, and S. Bulfone-Paus. 2006. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 17: 259-280. (Pubitemid 44038618)
10. Chirifu, M., C. Hayashi, T. Nakamura, S. Toma, T. Shuto, H. Kai, Y. Yamagata, S. J. Davis, and S. Ikemizu. 2007. Crystal structure of the IL-15-IL-15Ralpha complex, a cytokine-receptor unit presented in trans. Nat. Immunol. 8: 1001-1007. (Pubitemid 47300015)
11. Giri, J. G., M. Ahdieh, J. Eisenman, K. Shanebeck, K. Grabstein, S. Kumaki, A. Namen, L. S. Park, D. Cosman, and D. Anderson. 1994. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13: 2822-2830. (Pubitemid 24191692)
12. Dubois, S., J. Mariner, T. A. Waldmann, and Y. Tagaya. 2002. IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity 17: 537-547. (Pubitemid 35351500)
13. Johnston, J. A., C. M. Bacon, D. S. Finbloom, R. C. Rees, D. Kaplan, K. Shibuya, J. R. Ortaldo, S. Gupta, Y. Q. Chen, J. D. Giri, et al. 1995. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc. Natl. Acad. Sci. USA 92: 8705-8709.
14. Lucas, M., W. Schachterle, K. Oberle, P. Aichele, and A. Diefenbach. 2007. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26: 503-517. (Pubitemid 46602996)
15. Mortier, E., T. Woo, R. Advincula, S. Gozalo, and A. Ma. 2008. IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J. Exp. Med. 205: 1213-1225. (Pubitemid 351679694)
16. Burkett, P. R., R. Koka, M. Chien, S. Chai, D. L. Boone, and A. Ma. 2004. Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis. J. Exp. Med. 200: 825-834. (Pubitemid 39362919)
17. Giron-Michel, J., A. Caignard, M. Fogli, D. Brouty-Boyé, D. Briard, M. van Dijk, R. Meazza, S. Ferrini, C. Lebousse-Kerdilès, D. Clay, et al. 2003. Differential STAT3, STAT5, and NF-kappaB activation in human hematopoietic progenitors by endogenous interleukin-15: implications in the expression of functional molecules. Blood 102: 109-117. (Pubitemid 36759643)
18. Fehniger, T. A., and M. A. Caligiuri. 2001. Interleukin 15: biology and relevance to human disease. Blood 97: 14-32. (Pubitemid 32061238)
19. Rowley, J., A. Monie, C. F. Hung, and T. C. Wu. 2008. Inhibition of tumor growth by NK1.1+ cells and CD8+ T cells activated by IL-15 through receptor beta/common gamma signaling in trans. J. Immunol. 181: 8237-8247.
20. Benahmed, M., B. Meresse, B. Arnulf, U. Barbe, J. J. Mention, V. Verkarre, M. Allez, C. Cellier, O. Hermine, and N. Cerf-Bensussan. 2007. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology 132: 994-1008. (Pubitemid 46440858)
21. Hoontrakoon, R., H. W. Chu, S. J. Gardai, S. E. Wenzel, P. McDonald, V. A. Fadok, P. M. Henson, and D. L. Bratton. 2002. Interleukin-15 inhibits spontaneous apoptosis in human eosinophils via autocrine production of granulocyte macrophage-colony stimulating factor and nuclear factor-kappaB activation. Am. J. Respir. Cell Mol. Biol. 26: 404-412. (Pubitemid 34253924)
22. Badolato, R., A. N. Ponzi, M. Millesimo, L. D. Notarangelo, and T. Musso. 1997. Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes. Blood 90: 2804-2809. (Pubitemid 27413491)
23. Alleva, D. G., S. B. Kaser, M. A. Monroy, M. J. Fenton, and D. I. Beller. 1997. IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition. J. Immunol. 159: 2941-2951. (Pubitemid 127681317)
24. Chen, J. P., N. S. Liao, S. L. Lai, L. Hsu, W. Y. Mao, M. C. Ku, and F. Liao. 2005. Reduced 2,4-dinitro-1-fluorobenzene-induced contact hypersensitivity response in IL-15 receptor alpha-deficient mice correlates with diminished CCL5/RANTES and CXCL10/IP-10 expression. Eur. J. Immunol. 35: 690-698. (Pubitemid 40425524)
25. Perera, L. P., C. K. Goldman, and T. A. Waldmann. 1999. IL-15 induces the expression of chemokines and their receptors in T lymphocytes. J. Immunol. 162: 2606-2612. (Pubitemid 29309280)
26. Gill, N., K. L. Rosenthal, and A. A. Ashkar. 2005. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection. J. Virol. 79: 4470-4478. (Pubitemid 40388384)
27. Davies, E., S. Reid, M. F. Medina, B. Lichty, and A. A. Ashkar. 2010. IL-15 has innate anti-tumor activity independent of NK and CD8 T cells. J. Leukoc. Biol. 88: 529-536.
28. Mian, M. F., E. A. Pek, K. L. Mossman, M. R. Stämpfli, and A. A. Ashkar. 2009. Exposure to cigarette smoke suppresses IL-15 generation and its regulatory NK cell functions in poly I:C-augmented human PBMCs. Mol. Immunol. 46: 3108-3116.
29. Kovacic, J. C., R. Gupta, A. C. Lee, M. Ma, F. Fang, C. N. Tolbert, A. D. Walts, L. E. Beltran, H. San, G. Chen, et al. 2010. Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice. J. Clin. Invest. 120: 303-314.
30. Yang, J., X. Liao, M. K. Agarwal, L. Barnes, P. E. Auron, and G. R. Stark. 2007. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev. 21: 1396-1408. (Pubitemid 46871042)
31. Moriuchi, H., M. Moriuchi, and A. S. Fauci. 1997. Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J. Immunol. 158: 3483-3491. (Pubitemid 127484070)
32. Pierce, J. W., R. Schoenleber, G. Jesmok, J. Best, S. A. Moore, T. Collins, and M. E. Gerritsen. 1997. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 272: 21096-21103. (Pubitemid 27373968)
33. Schall, T. J., J. Jongstra, B. J. Dyer, J. Jorgensen, C. Clayberger, M. M. Davis, and A. M. Krensky. 1988. A human T cell-specific molecule is a member of a new gene family. J. Immunol. 141: 1018-1025.
34. Levy, J. A. 2009. The unexpected pleiotropic activities of RANTES. J. Immunol. 182: 3945-3946.
35. Ratthé, C., and D. Girard. 2004. Interleukin-15 enhances human neutrophil phagocytosis by a Syk-dependent mechanism: importance of the IL-15Ralpha chain. J. Leukoc. Biol. 76: 162-168. (Pubitemid 38857183)
36. Kumar, D., J. Hosse, C. von Toerne, E. Noessner, and P. J. Nelson. 2009. JNK MAPK pathway regulates constitutive transcription of CCL5 by human NK cells through SP1. J. Immunol. 182: 1011-1020.
37. Liang, J., Y. Saad, T. Lei, J. Wang, D. Qi, Q. Yang, P. E. Kolattukudy, and M. Fu. 2010. MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-kappaB signaling. J. Exp. Med. 207: 2959-2973.
38. Song, H. Y., C. H. Régnier, C. J. Kirschning, D. V. Goeddel, and M. Rothe. 1997. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl. Acad. Sci. USA 94: 9792-9796. (Pubitemid 27408143)